Work

Abstract 347: Targeting the AICDA/RAD51 axis: A novel gain-of-function synthetic lethal therapy for the treatment of AICDA-expressing cancers

Year: 2018
Type: conference-abstract
Institution: Jackson Laboratory
Language: English
Open Access status: closed
OpenAlex ID: W2885971707
Cites:
Cited by:
Related to: 10